TD ASSET MANAGEMENT INC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,287,776
+256.5%
213,218
+195.7%
0.01%
+266.7%
Q2 2023$2,605,154
+4.0%
72,105
+7.0%
0.00%0.0%
Q1 2023$2,506,118
+2.2%
67,405
+24.6%
0.00%0.0%
Q4 2022$2,451,498
+12.5%
54,105
+73.8%
0.00%0.0%
Q3 2022$2,179,000
+4.3%
31,1350.0%0.00%
+50.0%
Q2 2022$2,090,000
-46.2%
31,135
-34.1%
0.00%
-50.0%
Q1 2022$3,884,000
-58.0%
47,235
-25.1%
0.00%
-50.0%
Q4 2021$9,246,000
-14.8%
63,031
+2.8%
0.01%
-27.3%
Q3 2021$10,850,000
+18.4%
61,331
+7.1%
0.01%
+22.2%
Q2 2021$9,162,000
+44.4%
57,240
+54.5%
0.01%
+28.6%
Q1 2021$6,347,000
-18.2%
37,054
+4.8%
0.01%
-22.2%
Q4 2020$7,763,000
+78.5%
35,344
+35.0%
0.01%
+50.0%
Q3 2020$4,349,000
+51.2%
26,190
+4.0%
0.01%
+50.0%
Q2 2020$2,876,000
+64.9%
25,190
+11.0%
0.00%
+33.3%
Q1 2020$1,744,000
-52.5%
22,690
-20.3%
0.00%
-40.0%
Q4 2019$3,670,000
+56.1%
28,477
-5.6%
0.01%
+25.0%
Q3 2019$2,351,000
-16.7%
30,177
+10.1%
0.00%0.0%
Q2 2019$2,822,000
+96.4%
27,400
+39.8%
0.00%
+100.0%
Q1 2019$1,437,000
+114.5%
19,600
+24.1%
0.00%
+100.0%
Q4 2018$670,000
-8.2%
15,800
+1.9%
0.00%0.0%
Q3 2018$730,000
+80.7%
15,500
+89.0%
0.00%0.0%
Q2 2018$404,000
+64.2%
8,200
+2.5%
0.00%
Q1 2018$246,0008,0000.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$116,595,21681.37%
ORACLE INVESTMENT MANAGEMENT INC 201,400$7,488,0527.25%
Paradigm Biocapital Advisors LP 1,396,779$51,932,2434.92%
Octagon Capital Advisors LP 750,000$27,885,0004.01%
Boxer Capital, LLC 2,000,000$74,3603.65%
Artal Group S.A. 1,537,709$57,1723.40%
Avoro Capital Advisors LLC 5,555,555$206,555,5353.06%
RTW INVESTMENTS, LP 3,643,114$135,450,9792.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 244,000$9,071,9202.53%
Kynam Capital Management, LP 499,853$18,584,5352.40%
View complete list of MIRATI THERAPEUTICS INC shareholders